• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西的肺癌。

Lung cancer in Brazil.

作者信息

Araujo Luiz Henrique, Baldotto Clarissa, Castro Gilberto de, Katz Artur, Ferreira Carlos Gil, Mathias Clarissa, Mascarenhas Eldsamira, Lopes Gilberto de Lima, Carvalho Heloisa, Tabacof Jaques, Martínez-Mesa Jeovany, Viana Luciano de Souza, Cruz Marcelo de Souza, Zukin Mauro, Marchi Pedro De, Terra Ricardo Mingarini, Ribeiro Ronaldo Albuquerque, Lima Vladmir Cláudio Cordeiro de, Werutsky Gustavo, Barrios Carlos Henrique

机构信息

. Instituto Nacional de Câncer José Alencar Gomes da Silva - INCA - Rio de Janeiro (RJ) Brasil.

. Instituto COI de Educação e Pesquisa, Rio de Janeiro (RJ) Brasil.

出版信息

J Bras Pneumol. 2018 Jan-Feb;44(1):55-64. doi: 10.1590/S1806-37562017000000135.

DOI:10.1590/S1806-37562017000000135
PMID:29538545
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6104542/
Abstract

Lung cancer is one of the most incident types of cancer and a leading cause of cancer mortality in Brazil. We reviewed the current status of lung cancer by searching relevant data on prevention, diagnosis, and treatment in the country. This review highlights several issues that need to be addressed, including smoking control, patient lack of awareness, late diagnosis, and disparities in the access to cancer health care facilities in Brazil. We propose strategies to help overcome these limitations and challenge health care providers, as well as the society and governmental representatives, to work together and to take a step forward in fighting lung cancer.

摘要

肺癌是巴西发病率最高的癌症类型之一,也是癌症死亡的主要原因。我们通过搜索该国有关预防、诊断和治疗的相关数据,对肺癌的现状进行了综述。本综述强调了几个需要解决的问题,包括吸烟控制、患者缺乏认识、诊断延迟以及巴西癌症医疗设施获取方面的差异。我们提出了一些策略,以帮助克服这些限制,并促使医疗保健提供者、社会和政府代表共同努力,在抗击肺癌方面向前迈进。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b75/6104542/9cb33583b1e5/1806-3713-jbpneu-44-01-00055-gf3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b75/6104542/ce63f1e8ba5b/1806-3713-jbpneu-44-01-00055-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b75/6104542/830af62997ef/1806-3713-jbpneu-44-01-00055-gf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b75/6104542/9cb33583b1e5/1806-3713-jbpneu-44-01-00055-gf3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b75/6104542/ce63f1e8ba5b/1806-3713-jbpneu-44-01-00055-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b75/6104542/830af62997ef/1806-3713-jbpneu-44-01-00055-gf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b75/6104542/9cb33583b1e5/1806-3713-jbpneu-44-01-00055-gf3.jpg

相似文献

1
Lung cancer in Brazil.巴西的肺癌。
J Bras Pneumol. 2018 Jan-Feb;44(1):55-64. doi: 10.1590/S1806-37562017000000135.
2
Smoking, mortality, access to diagnosis, and treatment of lung cancer in Brazil.巴西的吸烟状况、死亡率、肺癌诊断途径和治疗情况。
Rev Saude Publica. 2024 May 13;58:18. doi: 10.11606/s1518-8787.2024058005704. eCollection 2024.
3
The barriers to initiating lung cancer care in low-and middle-income countries.低收入和中等收入国家启动肺癌治疗的障碍。
Pan Afr Med J. 2020 Feb 12;35:38. doi: 10.11604/pamj.2020.35.38.17333. eCollection 2020.
4
Impact of the delay to start treatment in patients with lung cancer treated in a densely populated area of Brazil.巴西人口密集地区肺癌患者开始治疗延迟的影响。
Clinics (Sao Paulo). 2017 Nov;72(11):675-680. doi: 10.6061/clinics/2017(11)05.
5
[An interdisciplinary malignancy, the lung cancer in Hungary in 2006: epidemiology, prevention and access to therapy].[一种跨学科的恶性肿瘤——2006年匈牙利的肺癌:流行病学、预防与治疗途径]
Magy Onkol. 2006;50(3):207, 209-11, 213-5. Epub 2006 Nov 12.
6
Consensus study on the health system and patient-related barriers for lung cancer management in South Africa.南非肺癌管理的卫生系统及患者相关障碍的共识研究。
PLoS One. 2021 Feb 11;16(2):e0246716. doi: 10.1371/journal.pone.0246716. eCollection 2021.
7
Early diagnosis of lung cancer: the great challenge. Epidemiological variables, clinical variables, staging and treatment.肺癌的早期诊断:巨大挑战。流行病学变量、临床变量、分期与治疗。
J Bras Pneumol. 2006 May-Jun;32(3):221-7.
8
Addressing Disparities in Lung Cancer Screening Eligibility and Healthcare Access. An Official American Thoracic Society Statement.解决肺癌筛查资格和医疗保健获取方面的差异。美国胸科学会官方声明。
Am J Respir Crit Care Med. 2020 Oct 1;202(7):e95-e112. doi: 10.1164/rccm.202008-3053ST.
9
The burden of lung cancer in Latin-America and challenges in the access to genomic profiling, immunotherapy and targeted treatments.拉丁美洲的肺癌负担以及基因组分析、免疫疗法和靶向治疗可及性方面的挑战。
Lung Cancer. 2018 May;119:7-13. doi: 10.1016/j.lungcan.2018.02.014. Epub 2018 Mar 2.
10
[Waiting times for cancer care in four most frequent cancers in several French regions in 2011 and 2012].[2011年和2012年法国几个地区四种最常见癌症的癌症护理等待时间]
Bull Cancer. 2013 Dec;100(12):1237-50. doi: 10.1684/bdc.2013.1832.

引用本文的文献

1
Cost-effectiveness assessment of liquid biopsy for early detection of lung cancer in Brazil.巴西液体活检用于肺癌早期检测的成本效益评估。
PLoS One. 2025 Jul 29;20(7):e0328631. doi: 10.1371/journal.pone.0328631. eCollection 2025.
2
Physician distribution and income-inequality on lung cancer mortality in Brazil.巴西医生分布与收入不平等对肺癌死亡率的影响
BMC Res Notes. 2025 Jul 1;18(1):262. doi: 10.1186/s13104-025-07281-5.
3
Smoking, mortality, access to diagnosis, and treatment of lung cancer in Brazil.巴西的吸烟状况、死亡率、肺癌诊断途径和治疗情况。

本文引用的文献

1
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.1980 - 2015年全球、区域和国家249种死因的预期寿命、全死因死亡率和死因别死亡率:全球疾病负担研究2015的系统分析
Lancet. 2016 Oct 8;388(10053):1459-1544. doi: 10.1016/S0140-6736(16)31012-1.
2
Epidemiological changes in the histological subtypes of 35,018 non-small-cell lung cancer cases in Brazil.巴西35018例非小细胞肺癌病例组织学亚型的流行病学变化
Lung Cancer. 2016 Jul;97:66-72. doi: 10.1016/j.lungcan.2016.04.019. Epub 2016 Apr 29.
3
Rev Saude Publica. 2024 May 13;58:18. doi: 10.11606/s1518-8787.2024058005704. eCollection 2024.
4
Can predictive factors determine the time to treatment initiation for oral and oropharyngeal cancer? A classification and regression tree analysis.预测因素能否确定口腔和口咽癌的治疗开始时间?分类回归树分析。
PLoS One. 2024 Apr 17;19(4):e0302370. doi: 10.1371/journal.pone.0302370. eCollection 2024.
5
Lung cancer screening in Brazil: recommendations from the Brazilian Society of Thoracic Surgery, Brazilian Thoracic Association, and Brazilian College of Radiology and Diagnostic Imaging.巴西肺癌筛查:巴西胸外科学会、巴西胸科协会和巴西放射学和诊断影像学学院的建议。
J Bras Pneumol. 2024 Mar 22;50(1):e20230233. doi: 10.36416/1806-3756/e20230233. eCollection 2024.
6
The journey of stage III and IV non-small cell lung cancer patients in the Brazilian private healthcare system: a retrospective study.巴西私立医疗系统中III期和IV期非小细胞肺癌患者的就医历程:一项回顾性研究。
Front Oncol. 2023 Oct 18;13:1257003. doi: 10.3389/fonc.2023.1257003. eCollection 2023.
7
Siglec 15 as a biomarker or a druggable molecule for non-small cell lung cancer.Siglec 15 作为非小细胞肺癌的生物标志物或可成药靶点。
J Cancer Res Clin Oncol. 2023 Dec;149(19):17651-17661. doi: 10.1007/s00432-023-05437-z. Epub 2023 Oct 16.
8
EGFR Mutation Detection in Brazilian Patients With Non-Small-Cell Lung Cancer: Lessons From Real-World Data Scenario of Molecular Testing.巴西非小细胞肺癌患者的表皮生长因子受体突变检测:来自分子检测真实世界数据的经验教训。
JCO Glob Oncol. 2023 Sep;9:e2200426. doi: 10.1200/GO.22.00426.
9
Exploring regional disparities in lung cancer mortality in a Brazilian state: A cross-sectional ecological study.探讨巴西一州肺癌死亡率的地区差异:一项横断面生态研究。
PLoS One. 2023 Jun 23;18(6):e0287371. doi: 10.1371/journal.pone.0287371. eCollection 2023.
10
Association between Polymorphism of Genes , , , and and Susceptibility to Non-Small Cell Lung Cancer in the Brazilian Amazon.基因 、 、 、 和 多态性与巴西亚马孙地区非小细胞肺癌易感性的关系。
Genes (Basel). 2023 Feb 10;14(2):461. doi: 10.3390/genes14020461.
The Fraction of Cancer Attributable to Ways of Life, Infections, Occupation, and Environmental Agents in Brazil in 2020.
2020年巴西因生活方式、感染、职业和环境因素导致的癌症比例。
PLoS One. 2016 Feb 10;11(2):e0148761. doi: 10.1371/journal.pone.0148761. eCollection 2016.
4
Do Current Lung Cancer Screening Guidelines Apply for Populations With High Prevalence of Granulomatous Disease? Results From the First Brazilian Lung Cancer Screening Trial (BRELT1).现行肺癌筛查指南是否适用于肉芽肿性疾病高发人群?巴西首次肺癌筛查试验(BRELT1)的结果。
Ann Thorac Surg. 2016 Feb;101(2):481-6; discussion 487-8. doi: 10.1016/j.athoracsur.2015.07.013. Epub 2015 Sep 26.
5
Brazil's Challenges and Opportunities.巴西的挑战与机遇。
Int J Radiat Oncol Biol Phys. 2015 Jul 15;92(4):707-12. doi: 10.1016/j.ijrobp.2014.12.063.
6
Mutational Profile and New IASLC/ATS/ERS Classification Provide Additional Prognostic Information about Lung Adenocarcinoma: A Study of 125 Patients from Brazil.突变谱与新的国际肺癌研究协会/美国胸科学会/欧洲呼吸学会分类为肺腺癌提供了额外的预后信息:一项对125例巴西患者的研究。
Oncology. 2015;89(3):175-86. doi: 10.1159/000376552. Epub 2015 Apr 1.
7
Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).1995 - 2009年全球癌症生存情况监测:对来自67个国家279个基于人群的登记处的25,676,887例患者的个体数据进行分析(CONCORD - 2)
Lancet. 2015 Mar 14;385(9972):977-1010. doi: 10.1016/S0140-6736(14)62038-9. Epub 2014 Nov 26.
8
General thoracic surgery workforce: training, migration and practice profile in Brazil.巴西普通胸外科劳动力:培训、移民与执业概况
Eur J Cardiothorac Surg. 2015 Jan;47(1):e19-24. doi: 10.1093/ejcts/ezu411. Epub 2014 Nov 12.
9
Survival and prognostic factors in patients with non-small cell lung cancer treated in private health care.在私立医疗保健机构接受治疗的非小细胞肺癌患者的生存及预后因素
Rev Bras Epidemiol. 2014 Dec;17(4):1001-14. doi: 10.1590/1809-4503201400040017.
10
US lung cancer trends by histologic type.按组织学类型划分的美国肺癌趋势。
Cancer. 2014 Sep 15;120(18):2883-92. doi: 10.1002/cncr.28749. Epub 2014 Aug 11.